Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36.485
Filtrar
1.
Washington, D.C.; PAHO; 2022-11-18.
em Inglês | PAHO-IRIS | ID: phr-56767

RESUMO

In the context of the continuous emergence of additional Omicron sublineages, PAHO/WHO reiterates that the nomenclature established to address the potential public health impacts of variants and based on Greek letter labels has not changed. Nomenclatures based on phylogenetic analysis (ie, Pango Network, GISAID, and Nextstrain) can also be used to designate lineages or sublineages. However, other nomenclatures or nicknames are not official and should not be used. PAHO/WHO regularly assesses new Omicron sublineages. To date, there is no evidence of significant changes in the public health impact of these sublineages and no justification of the assignment of a new variant label.


Assuntos
COVID-19 , SARS-CoV-2 , Infecções por Coronavirus , América
2.
Washington, D.C.; PAHO; 2022-11-15.
em Inglês | PAHO-IRIS | ID: phr-56766

RESUMO

Since the onset of the pandemic in 2020 and up to November 15, 2022, a cumulative total of approximately 632 million COVID-19 cases including about 6.6 million deaths were reported from all six WHO regions. During epidemiological week (EW) 45, cases decreased in three regions while they increased in AMRO (17.2%), WPRO (15.5%) and SEARO (15%). COVID-19 deaths decreased in four regions while they increased in WPRO (13.9%) and EMRO (7%). Globally, approximately 2,342,510 new COVID-19 cases were reported in EW 45 (November 06, 2022-November 12, 2022) – a 1.8% increase compared to EW 44 (October 30, 2022- November 05, 2022) (Figure 1). For the same period, 7,774 new COVID-19 deaths were reported globally – a -27.5% relative decrease compared the previous week. In the region of the Americas, 438,698 cases and 3,366 deaths were reported in EW 45 - a 17.2% increase in cases and -2.2% decrease in deaths compared to the previous week. At the subregional level, COVID-19 cases increased in all four subregions (range: 4.9 – 66.8%). Deaths increased in two subregions – South America (17.2%) and Central America (6.7%), while the remaining two subregions reported a decline – North America (-6%) and the Caribbean and Atlantic Ocean islands (-15.8%). The overall weekly case notification rate for the region of the Americas was 42.9 cases per 100,000 population during EW 45 (36.6 the previous week). Between EW 45 and 44, the 14- day COVID-19 death rate was 6.7 deaths per 1 million population (7.6 the previous two weeks). Among 27 countries/territories in the region with available data, COVID-19 hospitalizations increased in 6 countries and territories (range: 1% - 150%) during EW 45 compared to the previous week. Among 20 countries and territories with available data, COVID-19 ICU admissions increased in 5 countries and territories (range: 1% - 600%).


Assuntos
COVID-19 , SARS-CoV-2 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Vacinas , Cobertura Vacinal , Emergências , Genômica , América , Região do Caribe
3.
Washington, D.C.; PAHO; 2022-11-17.
em Inglês | PAHO-IRIS | ID: phr-56764

RESUMO

In Haiti, Cholera cases continue to spread to new areas of the capital and to additional departments in the country. As of 15 November 2022, the Department of Epidemiology, Laboratories, and Research (DELR) confirmed 821 cases of cholera across 27 municipalities compared to 23 municipalities in the previous epidemiological week. 98.7% of confirmed cases were reported in the Ouest department. IN NUMBERS, as of 15 November 2022: 9,685 suspected cases; 821 confirmed cases; 8,146 hospitalized suspected cases; and 188 deaths.


Assuntos
Cólera , Vibrio cholerae , Haiti
4.
Washington, D.C.; PAHO; 2022-11-01.
em Inglês | PAHO-IRIS | ID: phr-56763

RESUMO

Since the notification of the first two confirmed cases of Vibrio cholerae O1 in the greater Port-au-Prince area on 2 October 2022, to 30 October 2022, the Haitian Ministry of Health (Ministère de la Santé Publique et de la Population, MSPP per its French acronym)2, reported a total of 3,429 suspected cases in 6 departments of the country, including 399 confirmed cases, 2,942 hospitalized suspected cases, and 89 registered deaths. This represents an increase of 82% in confirmed cases (N=180) and 62% in deaths (N=34) compared to the Update of October 25, 2022. To date, 3 departments have confirmed cases (Artibonite, Centre and Ouest). Of a total of 1,058 samples analyzed by the National Public Health Laboratory (LNSP for its acronym in French), 387 were confirmed (36.6% positivity rate).


Assuntos
Cólera , Vibrio cholerae , Haiti
5.
Washington, D.C.; PAHO; 2022-11-15.
em Inglês | PAHO-IRIS | ID: phr-56761

RESUMO

Since the notification of the first two confirmed cases of Vibrio cholerae O1 in the greater Port-au-Prince area on 2 October 2022, to 13 November 2022, the Haitian Ministry of Health (Ministère de la Santé Publique et de la Population, MSPP per its French acronym)2, reported a total of 9,076 suspected cases in 8 departments of the country, including 816 confirmed cases, 7,623 hospitalized suspected cases, and 175 registered deaths. This represents an increase of 33% in suspected cases (N=2,262), 25% in confirmed cases (N=163) and 22% in deaths (N=31) compared to the Update of November 8, 2022. To date, 4 departments have confirmed cases (Artibonite, Centre, Grand-Anse and Ouest). As of November 13th, the case fatality rate among suspected cases is 2%. Of a total of 2,019 samples analyzed by the National Public Health Laboratory (LNSP for its acronym in French), 639 were confirmed (40.4% positivity rate).


Assuntos
Cólera , Vibrio cholerae , Haiti
6.
Washington, D.C.; PAHO; 2022-11-01.
em Inglês | PAHO-IRIS | ID: phr-56759

RESUMO

Since the onset of the pandemic in 2020 and up to November 01, 2022, a cumulative total of 627.6 million COVID-19 cases including about 6.6 million deaths were reported from all six WHO regions. During epidemiological week (EW) 43, cases decreased in four regions while they increased in WPRO (4.8%) and AMRO (4.8%). COVID-19 deaths increased in four regions (range: 17.8 – 154.5%) while they decreased in EMRO (-14.7%) and EURO (-28.9%). Globally, approximately 2,425,190 new COVID-19 cases were reported in EW 43 (October 23, 2022-October 29, 2022) - a -15.6% decrease compared to EW 42 (October 16, 2022-October 22, 2022) (Figure 1). For the same period, 9,463 new COVID-19 deaths were reported globally – a -3.2% relative decrease compared the previous week. In the region of the Americas, 388,097 cases and 4,340 deaths were reported in EW 43 - a 4.8% increase in cases and 23.1% increase in deaths compared to the previous week. At the subregional level, COVID-19 cases increased in all subregions (range: 1.3 - 21.4%) except for the Caribbean and Atlantic Ocean Islands subregion (-12.5%). Similarly, deaths increased in North America (21.6) and South America (38.9%) while they decreased in Central America (- 39.6%) and Caribbean and Atlantic Ocean Islands subregion (-18.2%). The overall weekly case notification rate for the region of the Americas was 38 cases per 100,000 population during EW 43 (36.3 the previous week). Between EW 43 and 42, the 14-day COVID- 19 death rate was 7.7 deaths per 1 million population (6.9 the previous two weeks). Among 29 countries/territories in the region with available data, COVID-19 hospitalizations increased in 12 countries and territories (range: 0.7% - 120%) during EW 43 compared to the previous week. Among 22 countries and territories with available data, COVID-19 ICU admissions increased in 6 countries and territories (range: 3.2% - 100%).


Assuntos
COVID-19 , SARS-CoV-2 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Vacinas , Cobertura Vacinal , Emergências , Genômica , América , Região do Caribe
7.
Washington, D.C.; PAHO; 2022-11-25.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-56757

RESUMO

[WEEKLY SUMMARY]. North America: Influenza activity is moderate in the subregion, with the predominance of influenza A(H3N2) and co-circulation of influenza A(H1N1)pdm09 and influenza B (lineage undetermined). The SARS-CoV-2 activity was low, while RSV activity remained elevated. In Canada, the influenza epidemic began. In Mexico, influenza was at moderate-intensity levels. Increased influenza and RSV activity was reported across the United States. Caribbean: Influenza activity was moderate across the subregion with A(H3N2) virus predominance and co-circulation of influenza B (lineage undetermined). In contrast, SARS-CoV-2 activity remained low, although it appears to increase in Dominica and Haiti. In addition, increased influenza activity was reported in the Dominican Republic and Puerto Rico, while bronchiolitis remained elevated in Guadeloupe and Martinique. Central America: Influenza activity is increasing with the predominance of influenza A(H3N2) and the co-circulation of influenza B/Victoria. SARS-CoV-2 activity remained low in the subregion, except in El Salvador, where it increased. In Guatemala and Nicaragua, influenza activity continued to increase, with influenza-associated ILI activity increased in Guatemala. In addition, increased RSV activity was reported in El Salvador, Guatemala, and Panama. Andean: Influenza activity remained low, with the predominance of influenza A(H3N2) and co-circulation of influenza A(H1N1)pdm09 and B/Victoria. Overall, SARS-CoV-2 and RSV activity was low in the subregion. However, Bolivia reported increased influenza activity with influenza A(H1N1)pdm09 predominance and co-circulation of B/Victoria and A(H3N2) viruses, with SARI activity increased, with 20% influenza-associated hospitalizations. Brazil and Southern Cone: Influenza activity increased in the subregion, with influenza A(H3N2) predominance and co-circulation of influenza A(H1N1)pdm09 and influenza B/Victoria. SARS-CoV-2 activity has remained low, although Chile has shown increased activity. Argentina reported increased influenza activity with B (lineage undetermined) virus predominance. Chile reported increased influenza activity for this time of year at extraordinary-intensity levels; ILI was increased with 29% ILI cases positive for influenza, while increased SARI cases, although at low-intensity levels, 14% were positive for SARS-CoV-2 versus 6% influenza cases. RSV activity remained elevated in Brazil, but it is decreasing.


[RESUMEN SEMANAL]. América del Norte: la actividad de la influenza es moderada en la subregión, con predominio de influenza A(H3N2) y circulación concurrente de influenza A(H1N1)pdm09 e influenza B (linaje indeterminado). La actividad del SARS-CoV-2 estuvo baja, mientras que la actividad del VRS permaneció elevada. En Canadá, comenzó la epidemia de influenza. En México, la influenza estuvo en niveles de intensidad moderada. Se informó un aumento de la actividad de la influenza en todos los Estados Unidos. Caribe: la actividad de la influenza fue moderada en toda la subregión con predominio del virus A(H3N2) y circulación concurrente de influenza B (linaje indeterminado). Por el contrario, la actividad del SARS-CoV-2 se mantuvo baja, aunque parece aumentar en Dominica y Haití. Además, se informó un aumento de la actividad de la influenza en la República Dominicana y Puerto Rico, mientras que la bronquiolitis se mantuvo elevada en Guadalupe y Martinica. América Central: la actividad de la influenza está aumentando con el predominio de influenza A(H3N2) y circulación concurrente de influenza B/Victoria. La actividad del SARS-CoV-2 se mantuvo baja en la subregión, excepto en El Salvador, donde aumentó. En Guatemala y Nicaragua, la actividad de la influenza continuó aumentando, y la actividad de la ETI asociada a la influenza aumentó en Guatemala. Además, se informó un aumento de la actividad del VRS en El Salvador, Guatemala y Panamá. Países Andinos: la actividad de la influenza se mantuvo baja, con predominio de influenza A(H3N2) y circulación concurrente de influenza A(H1N1)pdm09 y B/Victoria. En general, la actividad del SARS-CoV-2 y del VRS estuvo baja en la subregión. Sin embargo, Bolivia reportó un aumento de la actividad de la influenza con predominio de influenza A(H1N1)pdm09 y circulación concurrente de los virus B/Victoria y A(H3N2), con aumento de la actividad de la IRAG, con un 20% de casos asociados a la influenza. Brasil y Cono Sur: la actividad de la influenza aumentó en la subregión, con predominio de influenza A(H3N2) y circulación concurrente de influenza A(H1N1)pdm09 e influenza B/Victoria. La actividad del SARS-CoV-2 se ha mantenido baja, aunque Chile ha mostrado una mayor actividad. Argentina notificó un aumento de la actividad por influenza con predominio del virus B (linaje indeterminado). Chile reportó una mayor actividad de influenza para esta época del año en niveles de intensidad extraordinaria; las ETI aumentaron con un 29 % de casos positivos para influenza, mientras que los casos de IRAG aumentaron, aunque en niveles de baja intensidad. El 14 % fue positivo para SARS-CoV-2 respecto a un 6 % de casos de influenza. La actividad del VRS se mantuvo elevada en Brasil, pero está disminuyendo.


Assuntos
Influenza Humana , COVID-19 , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
8.
Washington, D.C.; PAHO; 2022-11-21. (PAHO/NMH/RF/22-0037).
Não convencional em Inglês | PAHO-IRIS | ID: phr-56743

RESUMO

The World Health Organization (WHO) Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2030 (WHO Global Action Plan) recognizes the critical importance of reducing the level of exposure of individuals and populations to common risk factors of noncommunicable diseases (NCDs), including harmful use of alcohol. It particularly recommends taxing alcoholic beverages as one of the most cost-effective regulatory policies to prevent NCDs, as does the WHO Global Alcohol Action Plan 2022-2030. Indeed, harmful use of alcohol is associated with hundreds of health conditions and injuries, acute and chronic. Taxes on alcoholic beverages represent a triple win for governments, because they 1) improve population health, 2) generate revenue, and 3) have the potential to reduce long-term associated healthcare costs and productivity losses. While since 2008, WHO has monitored tobacco taxes and prices with standardized quantitative indicators, including the comparison of tobacco tax share levels across all Member States and time, comparable information on taxation of alcoholic beverages over time and across countries is not currently available. Such monitoring is important for analyzing trends, enabling standardized comparisons across countries, establishing best practices, and providing a powerful tool for advocacy. The Pan American Health Organization (PAHO) is committed to providing Member States with accurate, relevant, and internationally comparable information that they can use to guide the development of policy and to evaluate the impact of measures to prevent the harmful use of alcohol. This note describes the methodology that PAHO developed for estimating a tax share indicator and other tax policy and price indicators for alcoholic beverages, based on the methodology used by WHO to monitor prices and taxes applied on tobacco products. It outlines the definition of the scope and beverages for which the tax share is calculated; a description of the data collection and analysis process; and an explanation of key components of the tax share calculation. It also defines additional indicators on prices, affordability, and tax policies. 


Assuntos
Doenças não Transmissíveis , Fatores de Risco , Bebidas Alcoólicas , Impostos
9.
Washington, D.C.; PAHO; 2022-11-18.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-56730

RESUMO

[WEEKLY SUMMARY]. North America: Influenza activity is moderate in the subregion, with the predominance of influenza A(H3N2) and co-circulation of influenza A(H1N1)pdm09 and influenza B (lineage undetermined). The SARS-CoV-2 activity was low, while RSV activity remained elevated. In Canada, influenza activity is increasing. In Mexico, influenza was at moderate-intensity levels. Increased influenza activity was reported in the United States . Caribbean: Influenza activity remained low across the subregion with A(H3N2) virus predominance and co-circulation of influenza B (lineage undetermined). The SARS-CoV-2 activity was very low. Influenza activity is increasing in Jamaica and Puerto Rico. ILI activity remained elevated in Guadeloupe and Martinique. Central America: Influenza activity remained low but increased with the predominance of influenza A(H3N2) and the co-circulation of influenza B (lineage undetermined). SARS-CoV-2 activity remained low in the subregion. Guatemala and Nicaragua reported increased influenza activity with A(H3N2) predominance in the first and influenza B (lineage undetermined) in the latter. In addition, RSV activity increased in El Salvador and Guatemala. Andean: Influenza activity remained low, with the predominance of influenza A(H3N2) and co-circulation of influenza A(H1N1)pdm09 and B (lineage undetermined). Overall, SARS-CoV-2 and RSV activity was low in the subregion. Bolivia reported increased influenza activity with co-circulation of A(H3N2) and A(H1N1)pdm09. Brazil and Southern Cone: Influenza activity increased in the subregion, with influenza A(H3N2) predominance and co-circulation of influenza A(H1N1)pdm09 and influenza B/Victoria. SARS-CoV-2 activity has remained low . Argentina reported increased influenza activity with B (lineage undetermined) virus predominance, while Chile reported increased influenza activity for this time of year at high-intensity levels; ILI was increased with 35% ILI cases positive for influenza and 2.7% for SARS-CoV-2. In addition, RSV activity increased in Brazil. Global: Influenza activity increased, and where subtyped, influenza A(H3N2) viruses predominated. An increasing trend of influenza activity was observed in the northern hemisphere, while a plateau was observed in the southern hemisphere. In Europe, influenza activity followed an increasing trend but remained relatively low. Influenza A viruses predominated among the reported detections, with A(H3N2) viruses accounting for most subtyped influenza A viruses. In central Asia, Kazakhstan reported high influenza activity with B/Victoria lineage viruses predominating. In East Asia, influenza activity of predominantly influenza A(H3N2) remained stable at intermediate levels. In Western Asia, influenza activity was elevated. Influenza detections continued to increase in some countries of the Arabian Peninsula. In tropical Africa, influenza activity remained low, with detections of influenza A(H3N2), B/Victoria, and A(H1N1)pdm09 reported. In Southern Asia, influenza activity increased steeply, with elevated activity reported in Bhutan, Iran, and Pakistan. Most subtyped detections were influenza A(H3N2), followed by A(H1N1)pdm09, and a few influenza B detections. In South East Asia, detections of predominantly influenza A(H3N2) followed by influenza B and influenza A(H1N1)pdm09 decreased. In the temperate zones of the southern hemisphere, influenza activity appeared to decrease during this reporting period. In Oceania, influenza activity remained very low, with detections of influenza A(H1N1)pdm09 and influenza A(H3N2) and some B viruses in Australia. In Southern Africa, decreasing detections of influenza B/Victoria and influenza A(H3N2) were reported. SARS-CoV-2 positivity from sentinel surveillance increased slightly but remained under 10% after a long-term downtrend beginning in mid-2022. Activity rose sharply in the Region of the Americas, with percent positivity reaching 20%. In the European Region, positivity was stable at around 10%. The Western Pacific Region's positivity declined sharply but remained just above 10%. Positivity declined and was below 10% in all other regions. COVID-19 positivity from non-sentinel surveillance increased to over 10% due to increased positivity in South-East Asia and Western Pacific Regions.


[RESUMEN SEMANAL]. América del Norte: en general, la actividad de la influenza es moderada en la subregión, con predominio de influenza A(H3N2) y circulación concurrente de influenza A(H1N1)pdm09 e influenza B (linaje indeterminado). La actividad del SARS-CoV-2 estuvo baja en general mientras que la actividad del VRS se mantuvo elevada. En Canadá, la actividad de la influenza está aumentando, ubicándose en niveles de baja intensidad. En México, la influenza estuvo en niveles de intensidad moderada. Los Estados Unidos reportaron un aumento de la actividad de la influenza, a un nivel de baja intensidad. Caribe: la actividad de la influenza se mantuvo baja en toda la subregión con predominio del virus A(H3N2) y circulación concurrente de influenza B (linaje indeterminado). La actividad del SARS-CoV-2 estuvo muy baja en general. La actividad de la influenza está aumentando en Jamaica y Puerto Rico. La actividad de la ETI se mantuvo elevada en Guadalupe y Martinica. América Central: la actividad de la influenza permaneció baja, pero en aumento, con el predominio de influenza A(H3N2) y la circulación concurrente de influenza B (linaje indeterminado). La actividad del SARS-CoV-2 se mantuvo baja en la subregión en general. Sin embargo, Guatemala y Nicaragua reportaron una actividad aumentada de influenza con A(H3N2) en el primero e influenza B (linaje indeterminado) en el segundo. Además, la actividad de VRS estuvo elevada en El Salvador y Guatemala. Países Andinos: la actividad de la influenza se mantuvo baja, con predominio de influenza A(H3N2) y circulación concurrente de influenza A(H1N1)pdm09 y B (linaje indeterminado). En general, la actividad de SARS-CoV-2 y VRS estuvo baja en la subregión. Sin embargo, Bolivia notificó un aumento de la actividad por influenza con circulación concurrente de A(H3N2) y A(H1N1)pdm09. Brasil y Cono Sur: la actividad de la influenza aumentó en la subregión, con predominio de influenza A(H3N2) y circulación concurrente de A(H1N1)pdm09 e influenza B/Victoria. La actividad del SARS-CoV-2 se ha mantenido baja en general. Argentina notificó un aumento de la actividad por influenza con predominio del virus B (linaje indeterminado), mientras que Chile notificó un aumento de la actividad de la influenza para esta época del año en niveles de alta intensidad; las ETI aumentaron con un 35,1 % de casos de ETI positivos para influenza y un 2,7 % para SARS‑CoV‑2. Además, la actividad del VRS aumentó en Brasil. Global: la actividad de la influenza aumentó y, en muestras con subtipo determinado, predominaron los virus influenza A(H3N2). Se observó una tendencia creciente de la actividad de la influenza en el hemisferio norte, mientras que en el hemisferio sur se observó una meseta. En Europa, la actividad de la influenza siguió una tendencia creciente pero se mantuvo relativamente baja. De las detecciones reportadas predominaron los virus A; de los virus influenza A con subtipo, los virus A(H3N2) representaron la mayoría. En Asia central, Kazajstán notificó una alta actividad por influenza con predominio de B/Victoria. En el Este de Asia, la actividad de la influenza predominantemente A(H3N2) se mantuvo estable en niveles intermedios. En Asia occidental, la actividad de la influenza estuvo elevada. Las detecciones de influenza continuaron aumentando en algunos países de la Península Arábiga. En África tropical, la actividad de la influenza se mantuvo baja, con detecciones de influenza A(H3N2), B/Victoria y A(H1N1)pdm09. En el sur de Asia, la actividad de la influenza aumentó considerablemente, con actividad elevada en Bután, Irán y Pakistán. La mayoría de las detecciones con subtipo determinado fueron influenza A(H3N2), seguidas de A(H1N1)pdm09 y algunas detecciones de influenza B. En el sudeste asiático, disminuyeron las detecciones predominantemente de influenza A(H3N2), seguidas de influenza B e influenza A(H1N1)pdm09. En las zonas templadas del hemisferio sur, la actividad pareció disminuir durante el período de este informe. En Oceanía, la actividad de influenza permaneció muy baja, con detecciones de influenza A(H1N1)pdm09 e influenza A(H3N2) y algunos virus B en Australia. En el sur de África, se informaron detecciones decrecientes de influenza B/Victoria e influenza A(H3N2). Vigilancia centinela: la positividad de la COVID-19 aumentó ligeramente, manteniéndose por debajo del 10%, luego de una tendencia a la baja que a mediados de 2022. La actividad aumentó considerablemente en la Región de las Américas, con un porcentaje de positividad del 20 %. En la Región Europea, la positividad se mantuvo estable alrededor del 10 %, mientras que en la Región del Pacífico Occidental disminuyó drásticamente, manteniéndose por encima del 10%. La positividad disminuyó y estuvo debajo del 10% en todas las demás regiones.


Assuntos
Influenza Humana , COVID-19 , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
10.
Washington, D.C.; PAHO; 2022-11-17. (PAHO/NMH/NV/22-0035).
em Inglês | PAHO-IRIS | ID: phr-56728

RESUMO

Noncommunicable Diseases (NCDs) and their Risk Factors (RFs) represent a significant burden of disease and disabilities worldwide. According to data from the WHO Global Health Estimates 2019, in the region of the Americas, NCDs are responsible for 5.8 million deaths (81% of total deaths), of which 34% are deaths in people between 30-70 years old. Additionally, NCD poses a high burden in the region since the Americas ranks high compared with the other WHO regions in many of the common NCDs/RFs, such as overweight and obesity, alcohol consumption, and insufficient physical activity. The Pan American Health Organization/World Health Organization (PAHO/WHO) is committed to supporting countries to strengthen their national capacity on NCD surveillance, produce quality data and contribute to the use of data for policymaking. As part of this effort, PAHO has identified opportunities and strategies to produce data on NCDs to rapidly assess NCD policies and interventions using Rapid Mobile Phone Surveys (RaMPS) based on learnings from the COVID-19 pandemic. RaMPS have the potential to produce timely data on the implementation of the NCD Best Buys related to NCDs and their risk factors, supported by data on the population's behaviors, knowledge, attitudes, and practices regarding health and protective measures. RaMPS complements other NCD surveillance efforts and do not replace the implementation of household surveys. This document presents an overview of the initiative developed by PAHO to strengthen the surveillance of NCDs across the Region through the implementation of Rapid Mobile Phone Surveys.


Assuntos
Doenças não Transmissíveis , Fatores de Risco , COVID-19 , Vigilância em Desastres
11.
Washington, D.C.; PAHO; 2022-11-16. (PAHO/CDE/IMS/Monkeypox/22-0017).
em Inglês | PAHO-IRIS | ID: phr-56715

RESUMO

In the face of diseases that are transmitted by close contact, silence or inadequate or inaccurate communication encourages a group of people to be blamed and held responsible for their sexual practices. This guide presents information and strategies for the gay, bisexual and men who have sex with men communities, as well as communicators, health personnel and decision-makers, to avoid or mitigate the stigma and discrimination associated with the monkeypox outbreak.


Assuntos
Varíola dos Macacos , Vírus da Varíola dos Macacos , Infecções Sexualmente Transmissíveis , Estigma Social
12.
Washington, D.C.; PAHO; 2022-11-10.
em Inglês, Espanhol | PAHO-IRIS | ID: phr-56663

RESUMO

[WEEKLY SUMMARY]. North America: Influenza activity is low, but increasing in the subregion. Influenza A(H3N2) predominated with the co‑circulation of influenza A(H1N1)pdm09 and influenza B/Victoria. The SARS‑CoV‑2 activity was low overall, and RSV circulation continued to rise. In Canada, influenza was at baseline levels, with increased activity, and in Mexico, influenza was at moderate-intensity levels. In the United States, influenza activity increased, with A(H3N2) predominance. Caribbean: Influenza activity remained low across the subregion with A(H3N2) virus predominance. Influenza activity is increasing in Jamaica and Puerto Rico. The SARS-CoV-2 activity was raised in Dominica. Central America: Influenza activity remained low but increased with influenza A(H3N2) predominance and the co-circulation of influenza B (lineage undetermined). SARS-CoV-2 activity remained low in the subregion overall. Influenza activity increased in Guatemala with A(H3N2) predominance, and in Nicaragua increased with the circulation of influenza B (lineage undetermined). RSV activity is increased in Costa Rica and El Salvador. Andean: Influenza activity remained low, with the predominance of influenza A(H3N2) and co-circulation of influenza B/Victoria. Overall, SARS-CoV-2 and RSV activity was low in the subregion. However, Bolivia reported increased influenza activity with co-circulation of A(H3N2) and B/Victoria. Brazil and Southern Cone: Influenza activity increased in the subregion, with influenza A(H3N2) predominance and co-circulation of influenza A(H1N1)pdm09 and influenza B/Victoria. SARS-CoV-2 activity has remained low overall. Argentina, Chile, and Uruguay reported increased influenza activity, while RSV activity remains high in Brazil and Uruguay.


[RESUMEN SEMANAL]. América del Norte: la actividad de influenza es baja, pero está aumentando en la subregión. Predominó influenza A(H3N2) con circulación concurrente de influenza A(H1N1)pdm09 e influenza B/Victoria. La actividad de SARS-CoV-2 fue baja en general y la circulación del VRS siguió en aumento. En Canadá, la influenza se ubicó en los niveles basales, con mayor actividad, y en México, la influenza se situó en niveles de intensidad moderada. En los Estados Unidos aumentó la actividad de la influenza, con predominio de A(H3N2). Caribe: la actividad de la influenza se mantuvo baja en toda la subregión con predominio del virus A(H3N2). La actividad de la influenza está aumentando en Jamaica y Puerto Rico. En Dominica la actividad del SARS-CoV-2 estuvo elevada . América Central: la actividad de la influenza se mantuvo baja pero aumentó con el predominio de influenza A(H3N2) y la circulación concurrente de influenza B (linaje indeterminado). La actividad del SARS-CoV-2 se mantuvo baja en la subregión en general. La actividad de la influenza aumentó en Guatemala con predominio de A(H3N2), y en Nicaragua aumentó con la circulación de influenza B (linaje indeterminado). Se incrementó la actividad del VRS en Costa Rica y El Salvador. Países Andinos: la actividad de la influenza se mantuvo baja, con predominio de influenza A(H3N2) y circulación concurrente de influenza B/Victoria. En general, la actividad de SARS-CoV-2 y del VRS estuvo baja en la subregión. Sin embargo, Bolivia notificó un aumento de la actividad de la influenza con la circulación conjunta de A(H3N2) y B/Victoria. Brasil y Cono Sur: la actividad de la influenza aumentó en la subregión, con predominio de influenza A(H3N2) y circulación concurrente de influenza A(H1N1)pdm09 e influenza B/Victoria. La actividad del SARS-CoV-2 se ha mantenido baja en general. Argentina, Chile y Uruguay registraron un aumento de la actividad de la influenza, mientras que la actividad del VRS continúa alta en Brasil y Uruguay.


Assuntos
Influenza Humana , COVID-19 , SARS-CoV-2 , Betacoronavirus , Regulamento Sanitário Internacional , América , Região do Caribe , Influenza Humana , Regulamento Sanitário Internacional , América , Região do Caribe
13.
Washington, D.C.; PAHO; 2022-11-10.
em Inglês | PAHO-IRIS | ID: phr-56660

RESUMO

Since the notification of the first two confirmed cases of Vibrio cholerae O1 in the greater Port-au-Prince area on 2 October 2022, to 6 November 2022, the Haitian Ministry of Health (Ministère de la Santé Publique et de la Population, MSPP per its French acronym)2, reported a total of 6,814 suspected cases in 7 departments of the country, including 653 confirmed cases, 5,628 hospitalized suspected cases, and 144 registered deaths. This represents an increase of 64% in confirmed cases (N=254) and 62% in deaths (N=55) compared to the Update of November 1, 2022. To date, 4 departments have confirmed cases (Artibonite, Centre, Grand-Anse and Ouest). Of a total of 1,585 samples analyzed by the National Public Health Laboratory (LNSP for its acronym in French), 639 were confirmed (40.3% positivity rate).


Assuntos
Cólera , Vibrio cholerae , Haiti
14.
Washington, D.C.; PAHO; 2022-11-10.
em Inglês | PAHO-IRIS | ID: phr-56659

RESUMO

Since the onset of the pandemic in 2020 and up to November 08, 2022, a cumulative total of approximately 630 million COVID-19 cases including 6.6 million deaths were reported from all six WHO regions. During the epidemiological week (EW) 44, cases decreased in four WHO regions (range: -39 - -3.1%) while they increased in WPRO (9.9%) and SEARO (28.1%). Similarly, deaths decreased in four regions while they increased in WPRO (7.9%) and SEARO (535.3%). Globally, approximately 2,181,459 new COVID-19 cases were reported in EW 44 (October 30, 2022-November 05, 2022) - a -13% decrease compared to EW 43 (October 23, 2022- October 29, 2022) (Figure 1). For the same period, 9,504 new COVID-19 deaths were reported globally – a -10% relative decrease compared the previous week. In the region of the Americas, 372,002 cases and 3,407 deaths were reported in EW 44 - a -3.1% decrease in cases and -20.7% decrease in deaths compared to the previous week. At the subregional level, COVID-19 cases decreased all (range: -25.8 - -20.1%) but one subregion – North American subregion (3.6% increase), and deaths decreased in all four subregions (range: -27.4 - -11.4% decrease). The overall weekly case notification rate for the region of the Americas was 36.4 cases per 100,000 population during EW 44 (37.5 the previous week). Between EW 44 and 43, the 14-day COVID-19 death rate was 7.5 deaths per 1 million population (7.6 the previous two weeks). Among 26 countries/territories in the region with available data, COVID-19 hospitalizations increased in 10 countries and territories (range: 1.2% - 169.1%) during EW 44 compared to the previous week. Among 18 countries and territories with available data, COVID-19 ICU admissions increased in 7 countries and territories (range: 0.4% - 200%).


Assuntos
COVID-19 , SARS-CoV-2 , Coronavirus , Infecções por Coronavirus , Betacoronavirus , Vacinas , Cobertura Vacinal , Emergências , Genômica , América , Região do Caribe
15.
Washington, D.C.; PAHO; 2022-11-09. (PAHO/PHE/IMS/Cholera/22-0019).
em Inglês | PAHO-IRIS | ID: phr-56656

RESUMO

After more than three years without cases, Haiti reported on 2 October 2022 a cluster of cholera cases in the metropolitan area of Port-au-Prince. This cholera resurgence in Haiti is happening in a complex operational context, amid a volatile socio-political environment marked by blockades, fuel shortages, criminal gang activity and rampant insecurity. This Appeal focuses on addressing the immediate needs of the Haitian population in areas affected by the resurgence of cholera as well as protect the most vulnerable groups at risk of infection. This appeal seeks to support, expand and strengthen Government and partners’ health response efforts to manage and control cholera outbreaks to reduce mortality and morbidity, and limit its spread to other communities and departments. Immediate response efforts will target: The scaling-up of response capacities of the MSPP and health partners already operational on the ground to increase capacities for surveillance, care delivery, risk communication, etc.; the rapid reactivation of response structures and mechanisms established for the response to and elimination of the previous cholera outbreak (2012-2019); and the strengthening of preparedness and response capacities in other departments, in preparation for a potential geographical dissemination of the virus. Recognizing the risk of spread of the outbreak outside of Haiti, particularly to neighboring Dominican Republic that shares the island of Hispaniola with Haiti, these efforts will also support countries at risk of importation of cases.


Assuntos
Cólera , Cólera , Haiti
16.
Washington, D.C.; PAHO; 2022-11-09. (OPS/FPL/HL/22-0051).
em Inglês | PAHO-IRIS | ID: phr-56651

RESUMO

IN THIS EDITION: Exchange on communication strategies and generation of demand to improve COVID-19 and routine vaccination rates | Conversation with Daniel Salas, new chief of the PAHO Comprehensive Family Immunization Unit | COVID-19 vaccination in the Region of the Americas: Achievements and future challenges | El Salvador's Expanded Immunization Program prepares for national vaccination campaign as part of Vaccination Week in the Americas | IX Ad Hoc Meeting of the PAHO Technical Advisory Group on Vaccine-Preventable Diseases.


Assuntos
Imunização , Programas de Imunização , Doenças Preveníveis por Vacina , Vacinas contra COVID-19 , COVID-19 , América
17.
Washington, D.C.; PAHO; 2022-11-09.
em Inglês | PAHO-IRIS | ID: phr-56645

RESUMO

This report presents the results of a regional assessment of the status of school health and the health-promoting schools (HPS) approach conducted jointly by PAHO, UNESCO, UNICEF, and the World Bank during 2018–2019. The objectives of the assessment were to: 1) assess the context and broader policy environment of school health in the Latin America and Caribbean (LAC) region, including legislative frameworks; 2) identify the scope and form of school health programs and services available in the region, as well as opportunities for improvement, and 3) enable countries to share with each other their best practices and the lessons learned in developing and implementing school health policies, programs, and services. The assessment results also serve as a regional baseline for the initiative, launched in 2019 by the World Health Organization (WHO) and UNESCO, to make every school a health-promoting school. The results of this assessment are expected to contribute to strengthening the HPS approach in the LAC region on subnational, national, and regional levels, and to help accelerate progress toward achieving the SDGs for all children and adolescents in the region. This assessment was conducted before the COVID-19 pandemic. Its impact has underlined the prominent role and multiple benefits of schools as an environment for equitable protection and promotion of the health and well-being of children and adolescents during the pandemic and in the recovery phase.


Assuntos
Serviços de Saúde Escolar , Promoção da Saúde , Desenvolvimento Sustentável , COVID-19 , América , Região do Caribe
18.
Washington, D.C.; PAHO; 2022-11-04.
em Inglês | PAHO-IRIS | ID: phr-56643

RESUMO

The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The Region shows the highest number of years of healthy life lost (through either disability or premature death) due to diabetes worldwide. The high costs associated with its treatment produce a heavy economic burden. Its complications can seriously affect the quality of life of people living with diabetes, their families, and society and overload health systems. This report shows the latest internationally comparable data on diabetes and its main risk factors by year, country, and sex. It also includes a summary of the countries health systems’ response to diabetes, including national plans, targets, surveillance, guidelines, and access to essential drugs and technologies, and synthesizes information about diabetes-related complications and the close relationship between diabetes and other pathologies, such as cardiovascular diseases, tuberculosis, and COVID-19. The data presented here reveal that, despite advances in national responses, diabetes continues to expand, and our response remains insufficient. This report aims to draw attention to the urgent need to strengthen efforts to prevent, diagnose, and control diabetes in the Region of the Americas.


Assuntos
Diabetes Mellitus , Glicemia , Doenças não Transmissíveis , COVID-19 , América
19.
Washington, D.C.; PAHO; 2022-11-04. (PAHO/FPL/IM/22-0025).
em Inglês | PAHO-IRIS | ID: phr-56642

RESUMO

The countries of the Americas, with support from the Pan American Health Organization (PAHO), have made remarkable progress in providing children with an umbrella of protection against basic vaccine-preventable diseases. Sustained high national immunization coverage levels, the eradication of polio, the interruption of endemic measles virus transmission, and efforts towards rubella and congenital rubella syndrome elimination are hemispheric benchmarks of this progress. Since 2020, the Region has also been facing the COVID-19 pandemic and major efforts have been taken to ensure administration of COVID-19 vaccines across all countries. Countries are now vaccinating age groups outside those usually targeted in the traditional childhood immunization program. Introducing seasonal influenza vaccine in adult populations at risk, vaccinating adolescents and adults, men, and women for rubella elimination, and defining the disease burden of cervical cancer are activities that support the critical need for national immunization programs to transition from child to family immunization. In support to countries, one of PAHO's roles is to disseminate information that can highlight progress and challenges faced in the Region. To that end, PAHO regularly publishes several technical documents related to immunization. The annually published "Immunization in the Americas" brochure summarizes immunization coverage in the Region of the Americas, in addition to illustrating the work done by the Region’s immunization programs for that year. Immunization in the Americas: 2022 Summary includes tables with the Region's demographic, morbidity, program management, financing, and socioeconomic data, as well as reported immunization coverage and surveillance indicators, among other items.


Assuntos
Imunização , Programas de Imunização , Vacinas , COVID-19 , América
20.
Washington, D.C.; PAHO; 2022-11-03. (PAHO/NMH/MH/22-0022).
em Inglês | PAHO-IRIS | ID: phr-56636

RESUMO

The World Health Organization global alcohol action plan 2022–2030 was endorsed by the Seventy-fifth World Health Assembly in May 2022 to effectively implement the global strategy to reduce the harmful use of alcohol as a public health priority. This factsheet presents a summary of the proposed indicators at global level for monitoring its implementation in the Americas.


Assuntos
Etanol , Consumo de Bebidas Alcoólicas , América
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...